National Deferred Long Term Liab from 2010 to 2024
| NRC Stock | USD 22.39 0.20 0.90% |
Deferred Long Term Liabilities | First Reported 2011-06-30 | Previous Quarter 5.3 M | Current Value 4.9 M | Quarterly Volatility 2.9 M |
Check National Research financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among National Research's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.4 M, Interest Expense of 1.5 M or Total Revenue of 156 M, as well as many indicators such as Price To Sales Ratio of 9.85, Dividend Yield of 0.0305 or PTB Ratio of 35.82. National financial statements analysis is a perfect complement when working with National Research Valuation or Volatility modules.
National | Deferred Long Term Liab |
Latest National Research's Deferred Long Term Liab Growth Pattern
Below is the plot of the Deferred Long Term Liab of National Research Corp over the last few years. It is liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue. National Research's Deferred Long Term Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in National Research's overall financial position and show how it may be relating to other accounts over time.
| Deferred Long Term Liab | 10 Years Trend |
|
Deferred Long Term Liab |
| Timeline |
National Deferred Long Term Liab Regression Statistics
| Arithmetic Mean | 3,928,742 | |
| Geometric Mean | 0.00 | |
| Coefficient Of Variation | 72.41 | |
| Mean Deviation | 2,247,822 | |
| Median | 4,204,000 | |
| Standard Deviation | 2,844,819 | |
| Sample Variance | 8.1T | |
| Range | 7.8M | |
| R-Value | 0.08 | |
| Mean Square Error | 8.7T | |
| R-Squared | 0.01 | |
| Significance | 0.77 | |
| Slope | 51,908 | |
| Total Sum of Squares | 113.3T |
National Deferred Long Term Liab History
About National Research Financial Statements
National Research stakeholders use historical fundamental indicators, such as National Research's Deferred Long Term Liab, to determine how well the company is positioned to perform in the future. Although National Research investors may analyze each financial statement separately, they are all interrelated. For example, changes in National Research's assets and liabilities are reflected in the revenues and expenses on National Research's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in National Research Corp. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Deferred Long Term Liabilities | 4.7 M | 3.4 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| S | SentinelOne | |
| MSFT | Microsoft | |
| MSFT | Microsoft |
Additional Information and Resources on Investing in National Stock
When determining whether National Research Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National Research's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Research Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Research Corp Stock:Check out the analysis of National Research Correlation against competitors. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Research. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Research listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.11) | Dividend Share 0.48 | Earnings Share 1.19 | Revenue Per Share 6.049 | Quarterly Revenue Growth (0.03) |
The market value of National Research Corp is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Research's value that differs from its market value or its book value, called intrinsic value, which is National Research's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Research's market value can be influenced by many factors that don't directly affect National Research's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National Research's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Research is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Research's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.